The FDA's recall currently lists bottles of 10-mg, 20-mg, 40-mg and 80-mg atorvastatin calcium tablets manufactured by India-based Alkem Laboratories and distributed by Ascend Laboratories as impacted medications. The recalled bottles contain different quantities of the tablets, ranging from 90-count to 1000-count bottles.